BI Consultancy

Activity: Consultancy

Description

To discuss clinical development plans for BI compound BI 1015550 PDE4B IPF and PF-ILD
Period2 Mar 2022
Work forBoehringer Ingelheim GmbH, Germany
Degree of RecognitionInternational